These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 1104668

  • 1. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses.
    Sudilovsky A, Clewe TH.
    J Clin Pharmacol; 1975; 15(11-12):779-84. PubMed ID: 1104668
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
    Jegasothy B, Jacobson C, Levine N, Millikan L, Olsen E, Pinnell S, Cole G, Weinstein G, Porter M.
    Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
    [Abstract] [Full Text] [Related]

  • 4. Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.
    Rampini E, Rastelli A, Divano C.
    Arzneimittelforschung; 1977 Sep; 27(12):2396-9. PubMed ID: 341903
    [Abstract] [Full Text] [Related]

  • 5. Fluocinonide vs halcinonide in atopic dermatitis. A paired comparison of two potent topical corticosteroids.
    Silverman A.
    Cutis; 1979 Mar; 23(3):375-8. PubMed ID: 369775
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Halcinonide in the treatment of corticosteroid responsive dermatoses.
    Leibsohn E, Bagatell FK.
    Br J Dermatol; 1974 Apr; 90(4):435-40. PubMed ID: 4596068
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of 0.1% halcinonide with 0.05% betamethasone dipropionate in the treatment of acute and chronic dermatoses.
    Levy A.
    Curr Med Res Opin; 1974 Apr; 5(4):328-32. PubMed ID: 343993
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of non-inflammatory dermatoses. A double-blind comparison of 1% hydrocortisone plus 10% urea and 0.05% fluocinonide.
    Khan SA.
    Practitioner; 1978 Aug; 221(1322):265-7. PubMed ID: 364458
    [No Abstract] [Full Text] [Related]

  • 12. Psoriasis: topical corticosteroid therapy.
    Lynfield Y, Watsky M.
    Cutis; 1976 Jul; 18(1):133, 136-7. PubMed ID: 797547
    [Abstract] [Full Text] [Related]

  • 13. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I, Cornell RC, Penneys NS, Zaias N.
    Clin Ther; 1986 Jul; 8(3):275-82. PubMed ID: 3521856
    [Abstract] [Full Text] [Related]

  • 14. A comparative clinical evaluation of a new topical steroid 'halcinonide' and hydrocortisone in steroid-responsive dermatoses.
    Fattah AA, El-Shiemy S, Faris R, Tadros SS.
    J Int Med Res; 1976 Jul; 4(4):228-31. PubMed ID: 1026547
    [Abstract] [Full Text] [Related]

  • 15. Double-blind paired comparison clinical trial of halcinonide and hydrocortisone.
    el-Hefnawi H, el-Shiemy S, Paris R, Tadros SS.
    Cutis; 1978 Jul; 22(1):97-9. PubMed ID: 352631
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985 Jul; 8(1):118-25. PubMed ID: 3914368
    [Abstract] [Full Text] [Related]

  • 17. Fluocinonide: a new topical corticosteroid for psoriasis and other dermatoses.
    Counce JH, Brass A.
    J La State Med Soc; 1972 Oct; 124(10):365-7. PubMed ID: 5079531
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K.
    Curr Med Res Opin; 1972 Oct; 4(10):703-5. PubMed ID: 800971
    [Abstract] [Full Text] [Related]

  • 19. Halcinonide, a new topical anti-inflammatory steroid.
    Savin RC.
    J Int Med Res; 1976 Oct; 4(1):34-6. PubMed ID: 799976
    [Abstract] [Full Text] [Related]

  • 20. A double-blind comparison of a new combination (halcinonide-neomycin-amphotericin) and active controls in cutaneous candidiasis and steroid-responsive dermatoses.
    Abdel-Aal H, Abdel-Fattah A, Shiemy S, Faris R, Tadros SS.
    J Int Med Res; 1976 Oct; 4(4):232-6. PubMed ID: 799995
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.